Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism

Mutagenesis

Volumn 12, Issue 6, 1997, Pages 431-435

  De Flora, Silvio ^a   Camoirano, Anna ^a   Cartiglia, Cristina ^a   Ferguson, Lynnette ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3,4 DIMETHYLIMIDAZO[4,5 F]QUINOLINE; 2 FLUORENYLAMINE; 3 AMINO 1 METHYL 5H PYRIDO[4,3 B]INDOLE; 6 CHLORO 9 [3 (2 CHLOROETHYL)AMINOPROPYLAMINO] 2 METHOXYACRIDINE; BENZO[A]PYRENE; CALCIUM CHANNEL BLOCKING AGENT; CALMODULIN INHIBITOR; CIGARETTE SMOKE CONDENSATE; DICHROMATE SODIUM; DOXORUBICIN; GLYCOPROTEIN P; HETEROCYCLIC AMINE; PROMUTAGEN; S 9; TRIFLUOPERAZINE; VERAPAMIL;

ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME INHIBITION; MULTIDRUG RESISTANCE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

BACTERIA (MICROORGANISMS); MAMMALIA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0030786171     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/12.6.431     Document Type: Article

References (37)

1. Baguley,B.C. and Ferguson,L.R. (1986) Verapamil modulates mutagenicity of antitumor acridines in bacteria and yeast. Biochem. Pharmacol., 56, 145-156.
2. Baguley,B.C., Turner, P.M. and Ferguson,L.R. (1990) Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae. Eur. J. Cancer, 26, 55-60.
3. Beck,W.T. (1990) Multidrug resistance and its circumvention. Eur. J. Cancer, 26, 513-515.
4. Clifford,S.C., Neal,D.E. and Lunec,J. (1996) High level expression of the multidrug resistance (MDR1) gene in the normal bladder urothelium: a potential involvement in protection against carcinogens? Carcinogenesis, 17, 601-604.
5. De Flora,S., Morelli,A., Zanacchi,P., Bennicelli,C. and De Flora,A. (1982) Selective deactivation of ICR mutagens as related to their distinctive pulmonary carcinogenicity. Carcinogenesis, 3, 187-194.
6. De Flora,S., Zanacchi,P., Camoirano,A., Bennicelli,C. and Badolati,G. (1984) Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat. Res., 133, 161-198.
7. De Flora,S., Camoirano,A., Izzotti,A., D'Agostini,F. and Bennicelli,C. (1989) Photoactivation of mutagens. Carcinogenesis, 10, 1089-1097.
8. De Flora,S., Bagnasco,M., Serra,D. and Zanacchi,P. (1990) Genotoxicity of chromium compounds. A review. Mutat. Res., 238, 99-172.
9. De Flora,S., Camoirano,A., Izzotti,A., Zanacchi,P., Bagnasco,M. and Cesarone,C.F. (1991) Antimutagenic and anticarcinogenic mechanisms of aminothiols. In Nygaard,F. and Upton,A.C. (eds), Anticarcinogenesis and Radiation Protection III, Plenum Press, New York, NY, pp. 275-285.
10. De Flora,S., Balansky,R., Gasparini,L. and Camoirano,A. (1995a) Bacterial mutagenicity of cigarette smoke and its interaction with ethanol. Mutagenesis, 10, 47-52.
11. De Flora,S., Bagnasco,M., Bennicelli,C., Camoirano,A., Bojnemirski,A. and Kurelec,B. (1995b) Biotransformation of genotoxic agents in marine sponges. Mechanisms and modulation. Mutagenesis, 10, 357-364.
12. De Flora,S., Camoirano,A., Bagnasco,M., Bennicelli,C., Corbett,G.E. and Kerger,B.D. (1997) Estimates of the chromium(VI) reducing capacity of organs, cell populations and fluids in the human body. Carcinogenesis, 18, 531-537.
13. Einistö,P., Watanabe,M., Ishidate,M.,Jr and Nohmi,T. (1991) Mutagenkity of 30 chemicals in Salmonella typhimurium strains possessing different NR or OAT activities. Mutat. Res., 259, 95-102.
14. Ferguson,L.R. and Baguley,B.C. (1988) Verapamil as a co-mutagen in the Salmonella/mammalian microsome mutagenicity test. Mutat. Res., 209, 57-62.
15. Ferguson,L.R. and Baguley,B.C. (1993) Multidrug resistance and mutagenesis. Mutat. Res., 285, 79-90.
16. Ferguson,L.R. and Baguley,B.C. (1996) Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes. Mutat. Res., 355, 91-101.
17. Ferguson,L.R., Turner,P.M. and Baguley,B.C. (1993a) Stimulation of bacterial mutagenicity by inhibitors of mammalian cell multidrug resistance. Mutat. Res., 264, 231-234.
18. Ferguson,L.R., Roberton,A.M., Watson,M.E., Kestell,P. and Harris,P.J. (1993b) The absorption of a range of dietary carcinogens by a-cellulose, a model insoluble dietary fibre. Mutat. Res., 319, 257-266.
19. Gottesman,M.M. and Pastan,J. (1988) The multidrug transporter, a doubleedged sword. J. Biol. Chem., 263, 12163-12166.
20. Kartner,N., Riordan,J.R. and Ling,V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285-1288.
21. Kurelec,B. and Pivcevic,B. (1991) Evidence for a multixenobiotic resistance mechanism in a mussel Mytlilus galloprovincialis. Aquat. Toxicol., 19, 291-302.
22. Ling,V. (1992) P-Glycoprotein and resistance to anticancer drugs. Cancer, 69, 2603-2609.
23. Maron,D.M. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
24. McGrath,J.P. and Varshavsky,A. (1989) The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature (Lond.), 340, 400-404.
25. Neyfakh,A.A., Bidnenko,V.E. and Chen,L.B. (1991) Efflux-mediated multidrug resistance in Bacillus subtilis - similarities and dissimilarities with the mammalian system. Proc. Natl Acad. Sci. USA, 88, 4781-4785.
26. Pajeva,I.K., Wiese,M., Cordes,H.P. and Seydel,J.K. (1996) Membrane interactions of some catamphiphilic drugs and relation to their multidrug- resistance-reversing ability. J. Cancer Res. Clin. Oncol., 122, 27-40.
27. Schrenk,D., Gant,T.W., Michalke,A., Orzechowski,A., Silverman,J.A., Battula,N. and Thorgeirsson,S.S. (1994) Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis, 15, 2541-2546.
28. Srivastava,R.K., Srivastava,A.R. and Chochung,Y.S. (1996) Multidrug resistance in cancer. Int. J. Oncol., 9, 879-884.
29. Sugimura,T. (1985) Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat. Res., 150, 33-41.
30. Takeshita,H., Gebhart,M.C., Springfield,D.S., Kusuzaki,K, and Mankin,H.J. (1996) Experimental models for the study of drug resistance in osteosarcoma- P-glycoprotein-positive, murine osteosarcoma cell lines. J. Bone Joint Surg. Am. Vol., 78A, 366-375.
31. Wakabayashi,K., Nagao,M., Esumi,H., Sugimura,T. (1992) Food-derived mutagens and carcinogens. Cancer Res., 52 (suppl. 1), 2092s-2098s.
32. Waldmann,P., Pivcevic,B., Muller,W.E.G., Zahn,R.K. and Kurelec,B. (1995) Increased genotoxicity of acetylaminofluorene by modulators of multixenobiotic resistance mechanism: studies with the freshwater clam Corbicula fluminea. Mutat. Res., 342, 113-123.
33. Weinstein,I.B. (1988) Strategies for inhibiting multistage carcinogenesis based on signal transduction pathways. Mutat. Res., 202, 413-420.
34. Wilson,C.M., Serrano,A.E., Wasley,A., Bogenschutz,M.P., Shankar,A.H. and Wirth,D.F. (1989) Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science, 244, 1184-1186.
35. Wu,C.T., Budding,M., Griffin,M.S. and Croop,J.M. (1991) Isolation and characterisation of Drosophila multidrug resistance gene homologues. Mol. Cell. Biol., 11, 3940-3948.
36. Yamashita,M., Wakabayashi,K., Nagao,M., Sato,S. Yamaizuni,Z., Takahashi,M., Kinae,N., Tomita,I. and Sugimura,T. (1986) Detection of 2-amino-3-methylimidazo[4,5-flquinoline in cigarette smoke condensate. Gann, 77, 419-422.
37. Yeh,G.C., Lopaczynska,J., Poore,C.M. and Phang,J.M. (1992) A new functional role for P-glycoprotein: efflux pump forbenzo(a)pyrene in human breast cancer MCF-7 cells. Cancer Res., 52, 6692-6695.